Journal
ANTIVIRAL RESEARCH
Volume 83, Issue 2, Pages 127-134Publisher
ELSEVIER
DOI: 10.1016/j.antiviral.2009.04.002
Keywords
Transient elastography; Hepatitis C virus; Pegylated interferon alpha; Ribavirin
Categories
Ask authors/readers for more resources
The aim of this study was to assess the association between liver stiffness measured by transient elastography (FibroScan (R)) and the efficacy of pegylated interferon alpha-2b plus ribavirin combination treatment for patients with chronic hepatitis C virus (HCV) infection. We prospectively studied 145 Japanese patients with chronic HCV infection. FibroScan was done at baseline, at the end of treatment, and at 48 and 96 weeks after the end of treatment. The FibroScan values were significantly decreased for sustained virological response (SVR) patients (the mean rate of change; -16.2%, -32.2% and -43.5%) in comparison with non-SVR patients (-7.2%, -2.1% and +17.3%) at the end of treatment (P = 0.0127), and 48 weeks (P < 0.0001) and 96 weeks (P < 0.0001) after the end of treatment. Among the non-SVR patients, the FibroScan values were significantly decreased for patients with biochemical response (BR) (-17.9%, -30.0% and -27.1%) in comparison with non-BR (-4.1%, +6.4% and +30.6%) at the end of treatment (P = 0.0270), and 48 weeks (P < 0.0001) and 96 weeks (P < 0.0001) after the end of treatment. The FibroScan values may predict a progressively better clinical outcome for patients with successful virological and biochemical responses. (C) 2009 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available